Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorgival Caetano

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Arquivos De Neuro-Psiquiatria|June 18, 2002
Acute psychotic disorders induced by topiramate: report of two casesFlorindo Stella, Dorgival Caetano, Fernando Cendes, et al.
Sao Paulo Medical Journal = Revista Paulista De Medicina|January 31, 2007
Factors influencing psychotropic prescription by non-psychiatrist physicians in a nursing home for the elderly in BrazilFlorindo Stella, Dorgival Caetano, Jaime Lisandro Pacheco, et al.
Pharmacogenomics and Personalized Medicine|September 19, 2017
ABCB1 and ABCC1 single-nucleotide polymorphisms in patients treated with clozapineIrina Piatkov, Dorgival Caetano, Yolinda Assur, et al.
Journal of Clinical Psychopharmacology|February 13, 2016
Predicting Weight Gain in Patients Treated With Clozapine: The Role of Sex, Body Mass Index, and SmokingSue Lynn Lau, Christopher Muir, Yolinda Assur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 6, 2003
Neuropsychological performance and regional cerebral blood flow in obsessive-compulsive disorderAcioly L T Lacerda, Paulo Dalgalarrondo, Dorgival Caetano, et al.
Psychiatry Research|July 10, 2003
Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT studyAcioly L T Lacerda, Paulo Dalgalarrondo, Dorgival Caetano, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 1, 2017
CYP2C19*17 protects against metabolic complications of clozapine treatmentIrina Piatkov, Dorgival Caetano, Yolinda Assur, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Arquivos De Neuro-Psiquiatria|June 18, 2002
Acute psychotic disorders induced by topiramate: report of two casesFlorindo Stella, Dorgival Caetano, Fernando Cendes, et al.
Sao Paulo Medical Journal = Revista Paulista De Medicina|January 31, 2007
Factors influencing psychotropic prescription by non-psychiatrist physicians in a nursing home for the elderly in BrazilFlorindo Stella, Dorgival Caetano, Jaime Lisandro Pacheco, et al.
Pharmacogenomics and Personalized Medicine|September 19, 2017
ABCB1 and ABCC1 single-nucleotide polymorphisms in patients treated with clozapineIrina Piatkov, Dorgival Caetano, Yolinda Assur, et al.
Journal of Clinical Psychopharmacology|February 13, 2016
Predicting Weight Gain in Patients Treated With Clozapine: The Role of Sex, Body Mass Index, and SmokingSue Lynn Lau, Christopher Muir, Yolinda Assur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 6, 2003
Neuropsychological performance and regional cerebral blood flow in obsessive-compulsive disorderAcioly L T Lacerda, Paulo Dalgalarrondo, Dorgival Caetano, et al.
Psychiatry Research|July 10, 2003
Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT studyAcioly L T Lacerda, Paulo Dalgalarrondo, Dorgival Caetano, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 1, 2017
CYP2C19*17 protects against metabolic complications of clozapine treatmentIrina Piatkov, Dorgival Caetano, Yolinda Assur, et al.
Pageof 2